Close Menu

NEW YORK (GenomeWeb) – Kromatid said today that it has received a Fast-Track Small Business Innovation Research (SBIR) grant from the National Human Genome Research Institute to further develop its proprietary single-cell structural genomics platform.

The $206,597 grant was awarded on Aug. 1 and expires at the end of the year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.